Painters & Allied Trades District Council 82 Healt, et al v. Takeda Pharmaceutical Company Limited, et al
Case Number:
23-55742
Court:
Nature of Suit:
Companies
- American Association for Justice
- Eli Lilly & Co.
- Pharmaceutical Research & Manufacturers of America
- Takeda Pharmaceutical Co. Ltd.
- Washington Legal Foundation
Sectors & Industries:
-
June 17, 2025
9th Circ. Backs Class Cert. In Suit Over Diabetes Drug Risk
The Ninth Circuit refused to disband a class of third-party payors who claim Takeda Pharmaceutical and Eli Lilly & Co. hid their anti-diabetes drug's bladder cancer risks, finding no issue with a lower court's analysis of expert evidence showing prescriptions fell after the risks were disclosed.
-
November 14, 2024
Takeda Rips Cert. Order's 'Whale Of Assumption' At 9th Circ.
Takeda Pharmaceutical urged the Ninth Circuit on Thursday to reverse a ruling certifying a class of third-party payors who allege Takeda and Eli Lilly & Co. hid their anti-diabetes drug's bladder-cancer risks, arguing the lower court erroneously made a "whale of an assumption" that 56.7% of prescriptions wouldn't have been written with disclosures.